Pharmaceuticals market gets a mite overheated
City & Business
Sunday 20 August 1995
The asthma drugs market is estimated to be worth $6bn a year and is growing at more than 10 per cent annually. Asthma kills increasing numbers of people and impairs the lives of many more. Children in particular are more and more prone to the ailment. Not that asthma, per se, was much in any of the protagonists' minds on Friday. This bid battle is more about earnings multiples, international alliances and business strategies, plus a sprinkling of bluff and counter-bluff.
As we report on page 3, the temperature is already rising. I don't think there is much love lost between RPR's chief executive, Michel de Rosen, graduate of the exclusive Ecole Nationale d'Administration and a former diplomat, and the down-to-earth Fisons boss Stuart Wallis, a former tax accountant.
RPR has got off to a solid start. It is offering lots of cash. Even by the sky-high prices paid for drug companies in the last 12 months, pounds 1.7bn is not to be sneezed at. Measured in terms of a multiple ofsales or earnings, 240p a share compares favourably with other deals in that most bid-prone of sectors, pharmaceuticals.
Of course, Fisons' argument is that its 1995 figures are irrelevant. The company is changing so fast that you have to look at the likely 1996 figures. By next year, it hopes, it will have sold both its laboratory supplies business and its scientific instruments operation. (The horticultural products, for which Fisons is probably best known, went long ago.)
By Christmas Fisons should be sitting on a cash pile of around pounds 500m and starting to lavish it on an array of licensing deals, joint ventures and acquisitions. That, at any rate, is the plan, and it will be at the heart of the argument between Fisons and RPR.
The RPR line is that the competition to clinch such deals is intense. There simply aren't that many exciting products around. And fewer still have the potential individually to make much of a difference to Fisons' earnings. Moreover, RPR contends, Fisons has been painfully slow to negotiate such deals in the past. The abortive attempt to take over Medeva earlier this year demonstrated the problem, argues RPR.
Fisons will stress its record since Wallis arrived last year. It has streamlined itself into a pure drugs marketing company. It has two reasonable, though mature, products in Intal and Tilade; it has some exciting technology in the form of a dry powder inhaler; it has a well-regarded international sales force; it has a secure foothold in the respiratory market.
Whether all this is enough to draw out a white knight, especially one prepared to pay cash, is doubtful. Fisons may have a better chance in forcing a higher offer from RPR. The market thinks so: Fisons shares closed the week at 264.5p - 24.5p above the offer price. But even eliciting a hike in the bid price won't be easy.
Shareholders are faced with the choice between certain cash now or the vague prospect of greater capital gains if they sit things out. Wallis has done a brilliant job of disposing of Fisons' non-core assets over the last nine months. But he faces an even tougher selling job over the next few weeks - dissuading his investors from taking the money and running.
I CAN'T remember a time when WH Smith has not been regarded by the stock market as a bit of a dinosaur. It has the Woolies Disease even worse than Woolies: you can't help suspecting that shoppers wouldn't care terribly much if the stores ceased to exist. The management valiantly peddles the line that the shops are still (in retail jargon) "destination stores" - that customers deliberately go out of their way to shop at WH Smith outlets.
The reality is that specialist bookshops, music stores and card shops long ago removed any specific reason to shop at the core Smith's chain. The irony is that the wider Smith's group itself owns the very specialist chains - Virgin, Our Price and Waterstone's - that are cannibalising the core chain.
The traditional WH Smith shop nowadays is more of a "convenience store", without, alas, being all that convenient. That is why it is being raided on a second flank by supermarkets. Food retailers are cleaning up in traditional Smith's product areas like best-selling books, videos and greetings cards - piddly value items, true, but boasting some of the most mindboggling margins on the street.
The group's profits warning in May revealed how bad things had got. In an attempt to give WH Smith shops more appeal they are being kitted out with multi-media departments selling CD-Roms and fun-zones to attract more children. No one seems much impressed.
Meanwhile, other parts of the Smith's empire continue to suffer, not least newspaper wholesaling and the direly performing Do It All chain of DIY sheds. We'll know a bit more about the current state of trading on Wednesay, when Smith's reports its interim results.
The group is not helped by the uncertainty created by the imminent retirements of the chief executive, Sir Malcolm Field, and finance director John Napier. So far there is no sign of a successor to either. After the tribulations of the last few years, I can't see an internal candidate going down well with investors. And the company hardly looks enticing to external candidates. But WH Smith desperately needs a credible leader with fresh ideas about what to do about the core chain.
- 1 Russell Brand says he will 'probably' give up acting to focus on his revolution
- 2 Watch what happened when food critics were unknowingly served McDonald's
- 3 David Beckham's Haig Club whisky is exactly what’s wrong with the Highlands
- 4 Queen's first tweet: Reply telling Her Majesty to 'f*** off' broadcast on BBC News
- 5 #AskNigelFarage: Twitter starts hilarious Q&A for Ukip leader
Eleven members of same family hospitalised after eating deadly pufferfish
Oscar Pistorius was 'gun-toting', 'trigger-happy' and 'combustible' claims Reeva's mother
Phone-hacking: The Piers Morgan connection - Mirror admits some stories during Morgan's tenure may have been obtained by illegal means
Tony Blair 'says Ed Miliband will lose 2015 general election'
Russell Brand says he will 'probably' give up acting to focus on his revolution
Of course, teenage girls need role models – but not like beauty vlogger Zoella
Support for EU membership 'at highest level since 1991' with most Brits wanting to stay 'in'
Tony Blair 'says Ed Miliband will lose 2015 general election'
Thousands with degenerative conditions classified as 'fit to work in future' – despite no possibility of improvement
Putin: The US is to blame for almost all the world's major conflicts
Poppy Appeal 2014: This is why I won't be wearing a red poppy this year
iJobs Money & Business
£60000 per annum: Ashdown Group: Compensation and Benefits Manager - Compensat...
£30000 - £35000 Per Annum plus excellent benefits: Clearwater People Solutions...
£24000 - £28000 per annum + bonus & benefits: Ashdown Group: IT Business Syste...
£50000 - £90000 per annum + benefits: Ampersand Consulting LLP: Markit EDM (CA...